Clinical Trial Update: Cabergoline in the Management of Nonfunctioning Pituitary Adenoma [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating cabergoline for the management of nonfunctioning pituitary adenoma, with enrollment currently by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonfunctioning Pituitary Adenoma
• Pituitary Adenoma

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pituitary Adenoma, MRI | Phase 4 | Status: ENROLLING_BY_INVITATION